n = 9 985
01.01.2006 - 31.12.2015
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
85.3%
Phaselto Phase II to Phase III to NDA/BLA to Phase I to Phase II Phase III NDA/BLA Approval Approval
■ Ali Diseases, Ali Modalities
Źródło: Clinical Devclopment Success Rates 2006-2015 - BIO Industry Analysis
Figuro 1. Phaso transition succoss ratos and LOA from Phase I for all disoasos, all modalitios.